Drug recall · April 26, 2017
CLENZIderm M.D. Pore Therapy Salicylic Acid 2% Acne Treatment 5 fl. oz recall
Why: Discoloration.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
CLENZIderm M.D. Pore Therapy Salicylic Acid 2% Acne Treatment 5 fl. oz. (148 mL), Valeant Pharmaceuticals North America LLC Distributed by OMP, Inc Long Beach, CA 90806 Made in USA. Product SKU 301876102042, NDC 0187-6102-04
- Lots / codes
Lot #: 15J1277, Exp. 04/2017
- Quantity
- 38,767 units
- Company
- Valeant Pharmaceuticals North America LLC, Bridgewater, NJ
- Distribution
- nationwide
- Initiated
- March 20, 2017 · Voluntary: Firm initiated
- Classified
- April 17, 2017
- Reported
- April 26, 2017
- Ended
- June 14, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Salicylic acid
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.